Items per page
1 - 157 of 157
Title Published in Access level OA Policy Year Views Downloads
Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic ModelingClinical pharmacokinetics
accessLevelPublic
2025 42 31
The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients : A Physiologically Based Pharmacokinetic Modeling StudyClinical pharmacology & therapeutics
accessLevelPublic
2025 52 72
Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxabanBritish journal of clinical pharmacology
accessLevelRestricted
2025 43 0
Simulation-Based Optimization of Sampling Schedules for Model-Informed Precision Dosing of Once-Daily and 4-Times-Daily Busulfan in Pediatric PatientsTherapeutic drug monitoring
accessLevelPublic
2024 5 3
Application of Microwave-Assisted Method for Lutein Extraction from Pistachio WasteJournal of nuts
accessLevelPublic
2024 95 168
Guidance on selecting optimal steady-state tacrolimus concentrations for continuous IV perfusion : insights from physiologically based pharmacokinetic modelingPharmaceuticals
accessLevelPublic
2024 86 49
Optimization of Lutein Extraction from Pistachio Waste Using Experimental Design and Ultrasonic MethodWaste and biomass valorization
accessLevelRestricted
2024 100 0
Stereoselective separation of omeprazole and 5-hydroxy-omeprazole using dried plasma spots and a heart-cutting 2D-LC approach for accurate CYP2C19 phenotypingJournal of chromatography. B
accessLevelPublic
2024 95 95
In vitro screening of UGT2B10 in silico prioritized putative ligands from drugs used in the pediatric hematopoietic stem cell transplantation settingPharmacology research & perspectives
accessLevelPublic
2024 74 39
Practice of CYP450 genotyping and phenotyping in children in a real-life settingFrontiers in pharmacology
accessLevelPublic
2023 69 101
Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic DrugsPharmaceutics
accessLevelPublic
2023 103 163
Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed sideCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2023 137 141
Evaluation of important human CYP450 isoforms and P-glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktailBasic & clinical pharmacology & toxicology
accessLevelRestricted
2023 112 0
Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with TramadolPharmaceuticals
accessLevelPublic
2023 59 32
Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCTTransplantation and cellular therapy
accessLevelPublic
2023 81 83
Impact of obesity and bariatric surgery on metabolic enzymes and p-glycoprotein activity using the Geneva cocktail approachJournal of personalized medicine
accessLevelPublic
2023 85 20
Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocolFrontiers in pain research
accessLevelPublic
2023 118 65
Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT studyCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2023 120 120
Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in HumansGenome biology and evolution
accessLevelPublic
2022 508 129
Editorial: Precision Medicine: Impact of Cytochromes P450 and Transporters Genetic Polymorphisms, Drug-Drug Interactions, Disease on Safety and Efficacy of DrugsFrontiers in pharmacology
accessLevelPublic
2022 182 117
Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and ResponsePharmaceuticals
accessLevelPublic
2022 77 20
Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6-hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spotsClinical and translational science
accessLevelPublic
2022 230 133
Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trialClinical and translational science
accessLevelPublic
2022 141 87
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World SettingJournal of personalized medicine
accessLevelPublic
2022 213 198
Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced ActivityFrontiers in psychiatry
accessLevelPublic
2022 93 93
Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patientsFrontiers in aging neuroscience
accessLevelPublic
2022 83 59
Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure SimulationClinical pharmacology and therapeutics
accessLevelPublic
2022 151 137
Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokineticsCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2022 263 374
Variations in the Frequencies of Polymorphisms in the CYP450s Genes in Eight Major Ethnicities of Iran: A Review of the Human DataJournal of personalized medicine
accessLevelPublic
2022 61 69
Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein ActivitiesClinical pharmacology & therapeutics
accessLevelPublic
2022 167 327
Personalized Medicine : PharmacokineticsJournal of personalized medicine
accessLevelPublic
2022 64 27
Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva CocktailClinical pharmacology and therapeutics
accessLevelPublic
2021 200 124
Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in MiceACS Nano
accessLevelPublic
2021 383 484
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug TherapyAnnual Review of Pharmacology and Toxicology
accessLevelRestricted
2021 438 1
Drug-drug interactions with direct oral anticoagulants: practical recommendations for cliniciansThe American journal of medicine
accessLevelRestricted
2021 158 0
Mixing Drugs and Genetics: A Complex Hemorrhagic CocktailAmerican Journal of Medicine
accessLevelRestricted
2021 277 5
CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical SettingFrontiers in pharmacology
accessLevelPublic
2021 269 193
The 1β-Hydroxy-Deoxycholic Acid to Deoxycholic Acid Urinary Metabolic Ratio: Toward a Phenotyping of CYP3A Using an Endogenous Marker?Journal of personalized medicine
accessLevelPublic
2021 216 49
Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activityBritish journal of pharmacology
accessLevelPublic
2021 314 129
The tyrosine kinase inhibitor nilotinib inhibits SARS‐CoV‐2 in vitroBasic & Clinical Pharmacology & Toxicology
accessLevelRestricted
2021 224 2
Simultaneous determination of melatonin and 6-hydroxymelatonin in human overnight urine by LC-MS/MSJournal of chromatography. B
accessLevelPublic
2021 415 355
Frequency of Important CYP450 Enzyme Gene Polymorphisms in the Iranian Population in Comparison with Other Major Populations: A Comprehensive Review of the Human DataJournal of personalized medicine
accessLevelPublic
2021 163 76
Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging TrendsFrontiers in pharmacology
accessLevelPublic
2021 174 181
Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic studyCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2021 241 123
Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatmentMolecular Oncology
accessLevelPublic
2020 431 173
Impact of enantiomer-specific changes in pharmacokinetics between infants and adults on the target concentration of racemic ketorolac: A pooled analysisBritish Journal of Clinical Pharmacology
accessLevelPublic
2020 222 157
Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic OriginsDrug Safety
accessLevelPublic
2020 702 225
Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva CocktailClinical Pharmacology and Therapeutics
accessLevelPublic
2020 320 431
GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteersEuropean Journal of Pain
accessLevelRestricted
2020 249 1
Bioavailability of Vortioxetine After a Roux-en-Y Gastric BypassObesity Surgery
accessLevelRestricted
2020 258 1
Deep proteomics and phosphoproteomics reveal novel biological pathways perturbed by morphine, morphine-3-glucuronide and morphine-6-glucuronide in human astrocytesJournal of Neuroscience Research
accessLevelRestricted
2020 305 2
Modern approaches for the phenotyping of cytochrome P450 enzymes in childrenExpert Review of Clinical Pharmacology
accessLevelRestricted
2020 205 1
Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in ChildrenTherapeutic Drug Monitoring
accessLevelPublic
2020 442 167
Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patientsJournal of Thrombosis and Haemostasis
accessLevelRestricted
2020 283 1
Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective StudyJournal of Personalized Medicine
accessLevelPublic
2020 347 89
Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva CocktailJournal of Personalized Medicine
accessLevelPublic
2019 460 197
Phenotyping of human CYP450 enzymes by endobiotics: current knowledge and methodological approachesClinical Pharmacokinetics
accessLevelRestricted
2019 415 3
Variables of interest to predict glomerular filtration rate in preterm newborns in the first days of lifePediatric Nephrology
accessLevelRestricted
2019 380 1
Towards personalized antithrombotic treatments: focus on P2Y12 inhibitors and direct oral anticoagulantsClinical Pharmacokinetics
accessLevelRestricted
2019 490 2
Drug-induced expression of the RNA-binding protein HuR attenuates the adaptive response to BRAF inhibition in melanomaBiochemical and Biophysical Research Communications
accessLevelPublic
2019 372 245
Liquid Chromatography-Tandem Mass Spectrometry Method for Ticagrelor and its Active Metabolite Determination in Human Plasma: Application to a Pharmacokinetic StudyCurrent Analytical Chemistry
accessLevelRestricted
2019 450 1
CYP450 activities before and after Roux-en-Y gastric bypass: correlation with their intestinal and liver contentSurgery for Obesity and Related Diseases
accessLevelRestricted
2019 356 0
Cytochrome P450 1A2 activity and incidence of thyroid disease and cancer after chronic or acute exposure to dioxinsBasic & Clinical Pharmacology & Toxicology
accessLevelRestricted
2019 461 4
Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer TreatmentIntegrative Cancer Therapies
accessLevelPublic
2019 368 118
Physiologically-based pharmacokinetic modeling for the prediction of CYP2D6-mediated gene-drug-drug interactionsCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2019 400 250
Perioperative intravenous low-dose ketamine for neuropathic pain after major lower back surgery: A randomized, placebo-controlled studyEuropean Journal of Pain
accessLevelRestricted
2019 391 2
Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modelingPediatric Research
accessLevelRestricted
2019 325 2
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active MetabolitesClinical Pharmacokinetics
accessLevelPublic
2018 718 721
Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical PerspectivesClinical Pharmacokinetics
accessLevelPublic
2018 509 707
Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory SettingJournal of Clinical Psychiatry
accessLevelRestricted
2018 483 0
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp softwareBiopharmaceutics & Drug Disposition
accessLevelRestricted
2018 617 12
Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomesBasic & Clinical Pharmacology & Toxicology
accessLevelPublic
2018 503 506
Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term PerformanceTherapeutic Drug Monitoring
accessLevelPublic
2018 848 577
Severe and persistent morphine-induced respiratory depression associated with ATP-Binding Cassette Subfamily B Member 1 and catechol-O-methyltransferase genetic defects: A case reportEuropean Journal of Anaesthesiology
accessLevelPublic
2018 438 317
Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)BMC Pharmacology & Toxicology
accessLevelPublic
2017 506 188
Impact of CYP2D6 functional allelic variations on phenoconversion and drug-drug interactionsClinical Pharmacology and Therapeutics
accessLevelRestricted
2017 485 5
Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferasesJournal of pharmaceutical and biomedical analysis
accessLevelPublic
2017 649 681
Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective studyPharmacological research
accessLevelPublic
2017 652 171
Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the futureClinical Pharmacology and Therapeutics
accessLevelRestricted
2017 583 0
The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell TransplantationFrontiers in Pharmacology
accessLevelPublic
2017 609 235
Hepatocyte Concentrations of Indocyanin Green (ICG) Reflects Transfer Rates Across Membrane TransportersBasic & clinical pharmacology & toxicology
accessLevelRestricted
2017 534 3
Plasma concentrations of transdermal fentanyl and buprenorphine in pigs (Sus scrofa domesticus)Veterinary Anaesthesia and Analgesia
accessLevelRestricted
2017 470 1
Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized MedicineJournal of Pharmaceutical Sciences
2017 481 0
Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosisFree radical biology & medicine
accessLevelPublic
2016 667 259
An extensive cocktail approach for rapid risk assessment of in vitro CYP450 direct reversible inhibition by xenobiotic exposureToxicology and applied pharmacology
accessLevelRestricted
2016 633 2
Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic DefectFrontiers in pharmacology
accessLevelPublic
2016 494 219
The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesiaNeuropharmacology
accessLevelPublic
2016 580 298
Detection of busulfan adducts on proteinsRCM. Rapid communications in mass spectrometry
accessLevelPublic
2016 653 185
Aspirin response: Differences in serum thromboxane B2 levels between clinical studiesPlatelets
accessLevelRestricted
2016 706 1
Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approachClinical pharmacology and therapeutics
accessLevelPublic
2016 655 723
Pharmacogenomics of Oral Antithrombotic DrugsCurrent pharmaceutical design
2016 615 0
Intestinal permeability and P-glycoprotein-mediated efflux transport of ticagrelor in Caco-2 monolayer cellsFundamental & clinical pharmacology
accessLevelRestricted
2016 614 21
Severe Vincristine-Induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case StudyClinical therapeutics
accessLevelRestricted
2016 547 2
Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling MethodBasic & clinical pharmacology & toxicology
accessLevelPublic
2016 667 485
Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant PrescriptionCurrent drug metabolism
accessLevelRestricted
2015 581 3
Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-ReviewCurrent drug metabolism
accessLevelRestricted
2015 635 6
Augmented renal clearance, low ß-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort studyInternational journal of antimicrobial agents
accessLevelRestricted
2015 821 3
GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteersPain
accessLevelRestricted
2015 617 3
Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a reviewCurrent drug metabolism
2014 648 0
Incorporation of Flurbiprofen in a 4-Drug Cytochrome P450 Phenotyping CocktailBasic & clinical pharmacology & toxicology
accessLevelRestricted
2014 641 4
Phenotyping of CYP450 in human liver microsomes using the cocktail approachAnalytical & bioanalytical chemistry
accessLevelRestricted
2014 529 2
Antiplatelet Therapy: Targeting the TxA2 PathwayJournal of cardiovascular translational research
accessLevelRestricted
2014 640 2
Geneva Cocktail for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood SpotsClinical pharmacology and therapeutics
accessLevelPublic
2014 908 387
Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activityAIDS research and therapy
accessLevelPublic
2014 719 926
The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantationPharmacogenomics journal
accessLevelRestricted
2014 715 8
Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic ModelCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2014 652 258
Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasmaBioanalysis
accessLevelRestricted
2014 756 5
Role of paraoxonase-1 in CYP2C19 loss-of-function carriersThrombosis research
accessLevelRestricted
2014 664 0
A cocktail approach for assessing the in vitro activity of human cytochrome P450s: An overview of current methodologiesJournal of pharmaceutical and biomedical analysis
accessLevelRestricted
2014 566 7
Antihyperalgesic Effect of the GABA(A) Ligand Clobazam in a Neuropathic Pain Model in Mice: A Pharmacokinetic-Pharmacodynamic StudyBasic & clinical pharmacology & toxicology
accessLevelPublic
2013 635 366
Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative propertiesArteriosclerosis, thrombosis, and vascular biology
accessLevelRestricted
2013 653 0
Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell modelBasic & clinical pharmacology & toxicology
accessLevelRestricted
2013 584 3
Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic modelThe journal of antimicrobial chemotherapy
accessLevelRestricted
2013 574 0
Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteersBasic & clinical pharmacology & toxicology
accessLevelPublic
2013 646 408
Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trialPain physician
accessLevelPublic
2013 616 1,075
Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute painPain physician
accessLevelPublic
2013 783 669
Applications of CYP450 Testing in the Clinical SettingMolecular diagnosis & therapy
accessLevelPublic
2013 753 846
Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing DrugsDrug metabolism and disposition
accessLevelPublic
2013 800 654
NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretionDiabetes
accessLevelPublic
2012 806 512
Transcriptional regulation of CYP2C19 and its role in altered enzyme activityCurrent drug metabolism
accessLevelRestricted
2012 597 0
Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patientAIDS
accessLevelPublic
2012 624 564
Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteersChimia
accessLevelPublic
2012 794 1,133
Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireviewBasic & clinical pharmacology & toxicology
accessLevelPublic
2012 642 677
Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysisJournal of thrombosis and haemostasis
accessLevelRestricted
2012 610 0
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitroBritish journal of pharmacology
accessLevelRestricted
2012 576 0
Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spotClinical pharmacology and therapeutics
2012 639 0
Analgesics in patients with hepatic impairment: pharmacology and clinical implicationsDrugs
accessLevelRestricted
2012 695 3
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infectionJournal of viral hepatitis
accessLevelRestricted
2012 654 0
A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometryRCM. Rapid communications in mass spectrometry
accessLevelPublic
2012 835 822
A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combinationBasic & clinical pharmacology & toxicology
accessLevelRestricted
2011 672 0
Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patientsMetabolism, clinical and experimental
2011 678 0
HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic painNeuropharmacology
accessLevelPublic
2011 801 625
How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liverThe Journal of pharmacology and experimental therapeutics
accessLevelPrivate
2011 624 0
Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metaboliteJournal of pharmaceutical and biomedical analysis
accessLevelPublic
2011 733 817
Two structurally different T-type Ca2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in ratsFundamental & clinical pharmacology
accessLevelRestricted
2011 11 0
The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodoneBritish journal of pharmacology
accessLevelRestricted
2010 856 2
Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variabilityCurrent drug metabolism
2010 659 0
Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safetyBritish journal of pharmacology
accessLevelRestricted
2010 633 1
Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoproteinBasic & clinical pharmacology & toxicology
accessLevelRestricted
2009 624 2
Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic studyJournal of chromatography
accessLevelRestricted
2009 554 0
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype predictionPharmacogenomics journal
accessLevelRestricted
2009 898 0
P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexoneFundamental & clinical pharmacology
accessLevelRestricted
2009 663 0
Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteersDrug metabolism letters
2008 849 0
Lack of interaction of the NMDA receptor antagonists dextromethorphan and dextrorphan with P-glycoproteinCurrent drug metabolism
accessLevelRestricted
2008 642 4
Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patientsJournal of chromatography. B
accessLevelRestricted
2008 611 4
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover studyClinical therapeutics
accessLevelRestricted
2007 758 0
Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humorJournal of chromatography. B
accessLevelRestricted
2005 603 2
Codeine intoxication associated with ultrarapid CYP2D6 metabolismThe New England journal of medicine
accessLevelRestricted
2004 546 1
High performance liquid chromatography of acarbose and its metabolite on porous graphitic carbon columnJournal of separation science
accessLevelRestricted
2002 936 1
Simultaneous analysis of polyhydroxylated alkaloids by capillary electrophoresis using borate complexation and evaluation of sweeping technique for sensitivity improvementChromatographia
accessLevelRestricted
2002 639 1
Calystegine distribution in some solanaceous speciesPhytochemistry
accessLevelRestricted
2001 634 0
Capillary electrophoresis and high-performance anion exchange chromatography for monitoring caseinoglycomacropeptide sialylationJournal of pharmaceutical and biomedical analysis
accessLevelRestricted
2001 553 0
Routine o-glycan characterization in nutritional supplements--a comparison of analytical methods for the monitoring of the bovine kappa-casein macropeptide glycosylationJournal of chromatography
accessLevelRestricted
2001 617 0
Use of borate complexation for the separation of non-UV-absorbing calystegines by capillary electrophoresisJournal of chromatography
accessLevelRestricted
2000 639 0
Partial solubility parameters of lactose, mannitol and saccharose using the modified extended Hansen method and evaporation light scattering detectionChemical and pharmaceutical bulletin
accessLevelRestricted
2000 562 0
Experimental design for enantioselective separation of celiprolol by capillary electrophoresis using sulfated beta-cyclodextrinElectrophoresis
accessLevelRestricted
1999 620 2
Development and validation of liquid chromatography and capillary electrophoresis methods for acarbose determination in pharmaceutical tabletsJournal of pharmaceutical and biomedical analysis
accessLevelRestricted
1998 623 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack